Nevertheless, the findings presented here not only advance our understanding of the local Ang II signaling involved in diabetes-related structural changes in the GI tract but also highlight the protective effects of AT1R blockade—offering a promising therapeutic strategy for preventing or mitigating diabetic GI remodeling. The gene discussed is AGTR1; the disease is diabetes mellitus.